// company-profile
Rapport Therapeutics, Inc. Insider Trading
RAPPEvery SEC Form 4 insider trading filing for Rapport Therapeutics, Inc. (RAPP) — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC.
curl "https://api.form4api.com/v1/transactions?ticker=RAPP" -H "X-Api-Key: YOUR_API_KEY"// activity-summary
Mixed insider activity over the last 30 days: 0 purchases and 0 sales (0 transactions total).
// 90-day insight
Over the last 90 days, Rapport Therapeutics, Inc. insiders bought $0 across 8 transactions with no open-market sales.
- Most active insider: Ceesay Abraham with 6 transactions totaling $749K.
- Largest single sale: $5.4M by Third Rock Ventures V, L.P. on May 11, 2026.
- 100% of recent sales were pre-scheduled 10b5-1 trades — typically less informative than open-market activity.
Activity skews bullish — buys outpace sales.
Institutional Ownership
Top 13F-HR holders of Rapport Therapeutics, Inc. as of 2026-06-30
Data source: quarterly 13F-HR filings — institutional holders report positions within 45 days of quarter end. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 27, 2026 | Ceesay Abraham | RAPP | Sale10b5 | 2,203 | $42.11 | $93K |
| Jul 27, 2026 | Ceesay Abraham | RAPP | Sale10b5 | 7 | $42.73 | $0K |
| Jul 14, 2026 | Ceesay Abraham | RAPP | Sale10b5 | 2,729 | $40.57 | $111K |
| Jul 14, 2026 | Ceesay Abraham | RAPP | Sale10b5 | 5,481 | $39.72 | $218K |
| Jun 30, 2026 | Gault Cheryl | RAPP | Sale10b5 | 3,308 | $42.17 | $140K |
45 more transactions hidden
Free account · No credit card required
Building something? Get API access →